4Murawaki Y, Ikuta Y, Okamoto K, et al. Diagnostic value of serum markers of connective turnover for predicting histological staging and grading in patients with chronic hepatitis C[J]. J Gastroenterol, 2001, 36(6):399-406.
7Gabrielli G B, Capra F, Casaril M, et al, Serum lamin in plin chronic viral hepatitis: correlations with liver histological activity and diagnostic value[J], Clin China Acta, 1996,252(2):171.
9Demirci G, Nashan B, Pichlmayr R, et al. Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGF-betal and TGF-beta3[J]. Transplanation, 1996, 62( 12): 1776.
10Eghbali-Fatourechi G, Sieck G C, Prakash Y S, et al. Type I procollagen production and proliferation is mediated by transforming grow the factor-βin a model of hepatic fibrosis [J]. Endocrinology, 1996,137(5): 1879.
3[1]Lawrence DA. Transforming growth factor-β: An overview. Kidney Int, 1995,47: s-19-23.
4[2]Barnard JA, Lyons RM, Moses HM. The cell biology of transforming growth factor β. Biotic Biopsy Acct,1990,1032:79-87.
5[3]Bodes P, Parades V. Transforming growth factor-β: a key-role in liver fibrogenesis. J Hepatol, 1995,22 (Suppl. 2): 37-42.
6[4]Asian RK, Sporran MB. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol,1986,102:1217-1223.
7Walsh KM,Timms P,Campbell S.et al. Plasma levels of M MP-2 and TIMP-1 and TIMP-2 as noninvasive markers of liver disease in chronic hepatitis C :comparison using ROC analysis[J]. Dig Dis Sci,1999,44(3) :624.
8Ninoniya T, Yoon S, Hayashi Y.et al. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic C patient treated with interferon-alpha histological evaluation by a modified histology ic al activity index scoring system[J]. J Gastroenterol Hepatol,1998,13(1) :68.
9Kozlowska J, Loch T,Jablonska J, et al. Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin[J].Przegl Eoidemiol.2001.55(3) :451.
